Your browser doesn't support javascript.
loading
Catastrophic costs for tuberculosis patients in India: Impact of methodological choices.
Chatterjee, Susmita; Das, Palash; Stallworthy, Guy; Bhambure, Gayatri; Munje, Radha; Vassall, Anna.
Afiliação
  • Chatterjee S; Research Department, George Institute for Global Health, New Delhi, India.
  • Das P; Department of Medicine, University of New South Wales, Kensington, New South Wales, Australia.
  • Stallworthy G; Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Bhambure G; Research Department, George Institute for Global Health, New Delhi, India.
  • Munje R; Bill & Melinda Gates Foundation, Global Health Division, Seattle, Washington State, United States of America.
  • Vassall A; Research Department, George Institute for Global Health, New Delhi, India.
PLOS Glob Public Health ; 4(4): e0003078, 2024.
Article em En | MEDLINE | ID: mdl-38669225
ABSTRACT
As financial risk protection is one of the goals towards universal health coverage, detailed information on costs, catastrophic costs and other economic consequences related to any disease are required for designing social protection measures. End Tuberculosis (TB) Strategy set a milestone of achieving zero catastrophic cost by 2020. However, a recent literature review noted that 7%-32% TB affected households in India faced catastrophic cost. Studies included in the review were small scale cross-sectional. We followed a cohort of 1482 notified drug-susceptible TB patients from four states in India Assam, Maharashtra, Tamil Nadu, and West Bengal to provide a comprehensive picture of economic burden associated with TB treatment. Treatment cost was calculated using World Health Organization guidelines on TB patient cost survey and both human capital and output approaches of indirect cost (time, productivity, and income loss related to an episode) calculation were used to provide the range of households currently facing catastrophic cost. Depending on choice of indirect cost calculation method, 30%-61% study participants faced catastrophic cost. For over half of them, costs became catastrophic even before starting TB treatment as there was average 7-9 weeks delay from symptom onset to treatment initiation which was double the generally accepted delay of 4 weeks. During that period, they made average 8-11 visits to different providers and spent money on consultations, drugs, tests, and travel. Following the largest cohort of drug-susceptible TB patients till date, the study concluded that a significant proportion of study participants faced catastrophic cost and the proportion was much higher when income loss was considered as indirect cost calculation method. Therefore, ensuring uninterrupted livelihood during TB treatment is an absolute necessity. Another reason of high cost was the delay in diagnosis and costs incurred during pre-diagnosis period. This delay and consequently, economic burden, can be reduced by both supply side (intense private sector engagement, rapid diagnosis) and demand side (community engagement) initiatives. Reimbursement of expenses incurred before treatment initiation could be used as short-term measure for mitigating financial hardship.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: PLOS Glob Public Health Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: PLOS Glob Public Health Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia
...